1928 Diagnostics
1928 Diagnostics provides a bioinformatics platform that automates the analysis of raw sequencing data for microbiology labs. The software offers tools for whole genome sequencing, outbreak tracing, and antimicrobial resistance (AMR) profiling. The company serves healthcare professionals, contract research organizations, pharmaceutical firms, and academic institutions.
Visit websiteGothenburg, Sweden
Healthtech
Biotechnology
Bioinformatics
Diagnostics
Funding summary
- Total raised
- €3.5M
- Funding rounds
- 2
Investors in 1928 Diagnostics
Investors on record for 1928 Diagnostics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like 1928 Diagnostics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors